logo

Axogen, Inc. (AXGN)



Trade AXGN now with
  Date
  Headline
4/22/2019 7:06:47 AM Axogen Announces Completion Of Planned Interim Analysis And One-Time Enrollment Expansion For RECON Study
1/7/2019 9:07:07 AM AxoGen Reports Q4 Revenue Of At Least $23.4 Mln, A 38% YoY Increase; Reaffirms 2019 Guidance
1/7/2019 9:03:03 AM AxoGen Appoints Christopher Crisman As VP, U.S. Sales
7/10/2018 7:11:30 AM AxoGen Appoints Lisa Colleran To Board Of Directors
5/21/2018 7:03:19 AM AxoGen Elects Karen Zaderej As Chairman In Addition To Her Current Role As President And CEO
5/14/2018 7:12:25 AM AxoGen Announces Closing Of Public Offering Of 3.45 Mln Common Stock At $41/Shr
5/9/2018 7:21:48 AM AxoGen Announces Upsizing And Pricing Of Public Offering Of Common Stock
2/5/2018 7:26:02 AM William Blair Starts AxoGen, Inc. (AXGN) At Outperform
1/8/2018 7:15:17 AM AxoGen Sees Q4 Revenue To Be At Least $16.5 Mln, Up 45%
11/21/2017 6:46:12 AM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2018 Estimate To -0.31 From -0.22
11/21/2017 6:45:49 AM Wedbush Is Increasing AxoGen, Inc. (AXGN) 2018 Rev. Estimate To 83.6 M From 83.3 M
11/2/2017 12:25:08 PM Wedbush Is Raising AxoGen, Inc. (AXGN) FY17 Estimate To -0.35 From -0.42
11/2/2017 12:24:51 PM Wedbush Is Raising AxoGen, Inc. (AXGN) Q4 17 Estimate To -0.11 From -0.14
8/3/2017 1:02:45 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2018 Estimate To -0.22 From -0.21
  
 
>